Compare GSK plc (GSK) vs iShares Global Clean Energy ETF (ICLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs iShares Global Clean Energy ETF — how do they compare? GSK plc trades at $52.6 (market cap $101.34B), while iShares Global Clean Energy ETF trades at $18.4. The key difference: GSK plc pays a 3.49% dividend while iShares Global Clean Energy ETF pays none, and GSK plc is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| GSK | ICLN | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | — |
52-Week High | $61.18 | $23.75 |
52-Week Low | $36.20 | $13.41 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
ICLN is trading at $18.65, down 2.2% today amid bearish technical signals with 14 sell indicators versus 4 buy signals. The ETF has shown strong performance in 2026 with a 29% YTD return, outperforming the S&P 500, driven by AI momentum and high global energy prices. Recent news highlights clean energy sector strength with multiple ETF comparisons showing ICLN's competitive positioning against traditional energy and infrastructure funds.
The outlook remains cautiously optimistic as clean energy benefits from structural tailwinds including data center demand and global energy security concerns. Key risks include regulatory uncertainty from stalled US permits threatening $121 billion in investment and geopolitical tensions affecting Chinese solar manufacturers. Analyst sentiment appears mixed with some viewing the recent pullback as a buying opportunity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →
